![John R. Garrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de John R. Garrett
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Director Ejecutivo | - | - |
Glycosyn Health Initiatives, Inc. | Director/Miembro de la Junta | - | - |
Historial de carrera de John R. Garrett
Antiguos cargos conocidos de John R. Garrett.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Director/Miembro de la Junta | 16/04/2018 | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Canadá | 2 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
Empresas privadas | 2 |
---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Health Technology |
Glycosyn Health Initiatives, Inc. |
- Bolsa de valores
- Insiders
- John R. Garrett
- Experiencia